Clinical trial
A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves…
NCT00271167 · Inotek Pharmaceuticals Corporation, Industry · Terminated
Key facts
| NCT number | NCT00271167 |
|---|---|
| Title | A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass |
| Official title | A Phase II Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Tolerability, Safety, Pharmacokinetics and Efficacy of Intravenous INO-1001 in High Risk Subjects Undergoing Cardiopulmonary Bypass for Coronary Revascularization and/or Valve Surgery. |
| Lead sponsor | Inotek Pharmaceuticals Corporation, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Diseases, Postoperative Complications |
| Intervention type | Drug |
| Interventions | INO-1001 |
| Enrollment | 162 |
| Start date | Oct 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Dec 30, 2005 |
| Last update posted | Mar 25, 2015 |
| Countries | Australia, India, Israel, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: